Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab + XELOX in Advanced Colorectal Cancer
NCT01159171Phase 2Completed
- Sponsor
- Roche
- Start
- Jan 2006
- Primary completion
- Jul 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in colorectal cancer (CRC), sponsored by Roche. Started Jan 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT01159171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01159171.